YOLFTbeta
Starpharma Holdings Ltd

Starpharma Holdings Ltd

SPL · AU · Healthcare / Biotechnology

0.425AUD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.425
Open0.42
Day Range0.42 – 0.442
52-Week Range0.245 – 0.875
Volume542.64K
Market Cap388.80M
P/E (TTM)0.00
Forward P/E312.50
EPS-0.02
Dividend Yield0.00%
Beta0.72
50-Day Avg0.7631
200-Day Avg0.6081

About

Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development and commercialization of dendrimer technology for pharmaceutical, healthcare applications, life science, and other applications in Australia and internationally. The company offers VivaGel BV, a non-antibiotic vaginal gel for the treatment of bacterial vaginosis (BV) and prevention of recurrent BV; VIRALEZE, an antiviral nasal spray; and VivaGel condom, an antiviral condom coating. It also involved in the development of a dendrimer-enhanced product (DEP) delivery platform, consisting of DEP SN38 for the treatment of ovarian and colorectal cancer that is in Phase II clinical trial; DEP cabazitaxel for prostate and ovarian cancer treatment that is in Phase II clinical trial; and DEP docetaxel to treat pancreatic and other cancers that is in Phase II clinical trial. In addition, the company is developing DEP HER2 radiodiagnostic and DEP HER2 ADC to treat solid tumors; DEP technology for antibody-drug conjugates; and SPL7013 for vaginal gel, a treatment of bacterial vaginosis and prevention of recurrent BV, and an antiviral condom. It has a collaboration agreement with Medicxi to develop petalion therapeutics, a novel cancer therapy using Starpharma's dendrimer technology. Starpharma Holdings Limited was incorporated in 1997 and is based in Abbotsford, Australia.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMs. Cheryl Maley B.Sc., M.B.A.
  • Employees50
  • Headquarters4-6 Southampton Crescent, Abbotsford, VIC, Australia, 3067, Australia
  • Websitehttps://starpharma.com

Leadership

  • Ms. Cheryl Maley B.Sc., M.B.A.CEO, MD & Director · b. 1969
  • Mr. Justin CahillChief Financial and Operations Officer & Company Secretary
  • Ms. Sindy SmithCommunications & Investor Relations Manager
  • Ms. Miranda SowdenDirector of People & Culture

Financials

Income Statement

Currency: AUD1998-06-301999-06-302000-06-302001-06-302002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Revenue--1.61M1.96M384.70K1.48M1.39M2.05M500863.85K1.41M2.02M1.40M1.14M925.00K20.00K1.25M1.70M4.57M3.65M4.96M2.72M6.03M1.80M4.68M2.94M8.29M4.91M12.05M
Growth (%)---+21.99%-80.41%+285.99%-6.35%+47.37%-99.98%+172670.80%+63.45%+42.99%-30.46%-18.52%-19.14%-97.84%+6165.00%+35.43%+169.53%-20.27%+35.92%-45.13%+121.80%-70.20%+160.40%-37.23%+182.03%-40.74%+145.32%
Cost of Revenue--3.37M18.00K15.00K439.00K325.00K372.00K--------00000251.00K1.80M1.26M2.78M1.72M632.00K1.22M1.66M
Gross Profit----384.70K1.48M1.39M2.05M500863.85K1.41M2.02M1.40M1.14M925.00K20.00K1.25M1.70M4.57M3.65M4.96M2.47M4.23M539.50K1.91M1.22M7.66M3.69M10.39M
Gross Margin----100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%90.77%70.15%30.01%40.71%41.60%92.38%75.08%86.26%
Operating Expense----9.25M9.36M8.63M12.42M13.85M19.33M20.14M16.14M13.97M13.75M18.58M8.70M15.88M20.64M25.86M18.86M15.24M16.72M25.66M29.21M25.80M25.90M22.82M15.69M29.63M
Operating Income-2.54M-2.34M-3.54M-5.58M-8.87M-7.87M-7.24M-10.37M-13.85M-18.46M-18.73M-14.12M-12.56M-12.61M-17.65M-8.68M-14.63M-18.95M-21.29M-15.22M-10.29M-14.25M-21.43M-28.67M-23.89M-24.67M-15.16M-12.00M-19.23M
Operating Margin---220.13%-284.31%-2305.25%-530.15%-520.84%-506.21%-2770216.40%-2137.46%-1326.27%-699.55%-894.87%-1101.84%-1908.32%-43420.00%-1167.44%-1116.38%-465.46%-417.25%-207.48%-524.04%-355.20%-1594.49%-510.36%-839.50%-182.88%-244.26%-159.60%
EBITDA-2.54M-2.34M-3.54M-5.52M-8.69M-6.92M-6.66M-7.81M-5.89M-5.91M-6.10M-2.27M-4.67M-7.38M-12.51M-4.17M-13.53M-17.72M-21.74M-14.90M-11.43M-13.96M-19.44M-26.05M-22.34M-22.08M-9.63M-10.93M-18.32M
EBITDA Margin---220.13%-281.13%-2260.18%-466.33%-478.57%-380.93%-1178468.40%-684.69%-431.73%-112.58%-332.34%-645.28%-1352.22%-20850.00%-1079.97%-1044.43%-475.34%-408.53%-230.58%-513.09%-322.16%-1448.55%-477.06%-751.14%-116.20%-222.48%-152.04%
Net Income-1.27M-1.17M-1.77M-3.91M53.16K-175.06K-5.50M-7.59M-7.52M-7.24M-7.49M-4.13M-6.38M-8.93M-13.66M-5.23M-14.63M-18.95M-21.29M-15.22M-10.29M-14.25M-14.68M-19.73M-16.15M-15.64M-8.16M-9.99M-7.46M
Net Income Margin---110.06%-198.88%13.82%-11.79%-395.36%-370.18%-1504557.80%-838.68%-530.52%-204.41%-454.27%-780.59%-1476.54%-26145.00%-1168.00%-1116.68%-465.50%-417.25%-207.48%-524.04%-243.30%-1097.44%-345.02%-532.09%-98.50%-203.38%-61.95%
R&D--1.42M4.00M6.23M5.71M4.12M6.41M9.65M11.98M12.22M9.99M5.72M5.99M12.09M3.50M15.21M19.73M24.64M18.13M14.63M15.53M20.48M22.32M18.94M18.87M15.58M8.36M22.30M
R&D as % of Total Revenue--88.32%203.90%1618.91%384.77%296.22%312.80%1929583.20%1387.22%865.72%494.70%407.62%523.25%1306.81%17525.00%1214.13%1162.52%538.70%497.04%295.18%570.77%339.42%1241.55%404.55%642.06%187.96%170.09%185.05%
Interest Expense0000015.53K12.01K8.29K23.29K32.74K27.00K28.00K18.00K16.00K8.00K9.00K7.00K5.00K2.00K1.00K0000217.00K----
Interest Expense % of Total Revenue--0.00%0.00%0.00%1.05%0.86%0.40%4657.00%3.79%1.91%1.39%1.28%1.40%0.86%45.00%0.56%0.29%0.04%0.03%0.00%0.00%0.00%0.00%4.63%----

Balance Sheet

Currency: AUD1998-06-301999-06-302000-06-302001-06-302002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Assets--29.05M26.03M18.86M10.72M18.49M12.50M25.01M30.42M24.65M28.85M37.57M29.81M54.27M48.55M36.86M44.38M59.04M66.59M58.51M48.86M39.08M73.24M66.17M52.09M36.81M25.42M19.02M
Total Liabilities--199.28K1.11M1.59M1.47M898.45K2.53M3.70M4.70M4.27M3.35M2.72M2.11M5.62M2.58M3.91M6.83M9.62M5.61M5.23M6.46M7.75M10.94M17.78M17.27M8.70M6.42M5.24M
Total Equity--28.85M24.92M17.01M9.24M17.59M9.97M21.32M25.72M20.38M25.50M34.84M27.69M48.65M45.97M32.95M37.56M49.42M60.98M53.28M42.40M31.33M62.30M48.39M34.81M28.12M19.00M13.78M
Cash--28.08M25.41M17.43M7.89M15.66M8.17M14.28M10.07M7.48M11.60M22.85M18.92M42.81M33.84M24.03M30.85M45.97M61.19M51.32M41.25M30.05M60.50M49.92M35.18M23.36M15.41M11.02M
Total Debt-----263.53K203.52K139.76K457.50K328.73K417.00K293.00K160.00K66.00K140.00K100.00K75.00K48.00K18.00K70.00K49.00K26.00K1.57M1.17M8.19M8.27M3.53M2.40M707.00K
Net Debt---28.08M-25.41M-17.43M-7.63M-15.45M-8.03M-13.83M-9.74M-7.07M-11.30M-22.69M-18.85M-42.67M-33.74M-23.95M-30.80M-45.95M-61.12M-51.27M-41.23M-28.48M-59.33M-41.73M-26.91M-19.83M-13.01M-10.31M

Cash Flow

Currency: AUD2000-06-302001-06-302002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Operating Cash Flow--2.45M-7.31M--5.81M-5.81M-7.49M-3.38M-5.35M-4.03M-3.63M-6.48M-9.77M-9.79M-9.81M-13.62M-17.81M-16.95M-10.20M-10.34M-10.78M-14.81M-13.16M-13.53M-6.98M-6.76M-3.21M
Investing Cash Flow--183.00K-885.00K-2.50M-153.96K-1.62M-437.28K-272.16K-36.00K-47.00K-4.00K-138.00K-133.00K-156.00K-251.00K-653.00K29.00K32.66M-359.00K-306.00K-125.00K-246.00K-836.00K-610.00K-89.00K-42.00K-259.00K
Financing Cash Flow7.28M20.82M242.00K-56.47K13.73M-63.77K14.04M-126.74K3.40M6.81M14.96M3.51M33.66M828.00K203.00K20.47M32.56M-21.00K-26.00K-26.00K-584.00K46.30M3.23M-695.00K-4.75M-1.13M-876.00K
Capital Expenditure110.00K183.00K885.00K1.61M153.96K405.29K463.18K182.19K36.00K49.00K27.00K138.00K133.00K156.00K251.00K653.00K97.00K625.00K359.00K314.00K125.00K246.00K837.00K621.00K89.00K42.00K287.00K
Free Cash Flow--2.64M-8.20M-1.61M-5.96M-6.21M-7.95M-3.56M-5.39M-4.08M-3.66M-6.61M-9.90M-9.95M-10.06M-14.27M-17.91M-17.58M-10.56M-10.66M-10.90M-15.05M-14.00M-14.15M-7.07M-6.80M-3.50M
Dividends Paid---------------20.47M31.25M0---46.30M-----
FCF to OCF-107.46%112.11%-102.65%106.98%106.18%105.39%100.67%101.22%100.74%102.13%101.36%101.59%102.56%104.80%100.54%103.69%103.52%103.04%101.16%101.66%106.36%104.59%101.28%100.62%108.94%
Dividend Paid to FCF----------------143.47%-174.48%0.00%----307.58%-----

Earnings

Report DateFeb 24, 2014Aug 25, 2014Feb 17, 2016Aug 29, 2016Feb 27, 2017Aug 28, 2017Feb 26, 2018Aug 21, 2018Feb 26, 2019Aug 28, 2019Feb 23, 2020Aug 26, 2020Feb 24, 2021Aug 24, 2021Nov 9, 2021Feb 20, 2022Jun 1, 2022Aug 24, 2022Nov 8, 2022Feb 28, 2023Apr 28, 2023Aug 24, 2023Oct 31, 2023Feb 27, 2024May 29, 2024Aug 26, 2024Nov 29, 2024Mar 4, 2025May 28, 2025Aug 20, 2025Nov 28, 2025
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.000.000.00-0.00-0.00-0.00-0.000.000.000.000.000.000.000.000.00-0.00
EPS Actual0.000.00-0.03-0.06-0.02-0.04-0.02-0.01-0.02-0.02-0.02-0.02-0.03-0.020.00-0.020.00-0.020.00-0.020.000.000.000.000.000.000.00-0.010.00-0.010.00
Surprise-------------------------------
Timing---------------After-hours-After-hours-Pre-marketPre-marketPre-marketPre-market------Pre-market-

Key Statistics & Ratios

Market Cap388.80M
Enterprise Value378.49M
Trailing P/E0.00
Forward P/E312.50
PEG Ratio0.00
Price / Sales30.69
Price / Book28.22
EPS-0.02
Book Value0.033
Revenue (TTM)12.67M
Gross Profit (TTM)774.00K
EBITDA-7.18M
Profit Margin-58.93%
Operating Margin-583.74%
Return on Equity-45.55%
Return on Assets-21.00%
Shares Outstanding477.05M
Shares Float350.04M
Beta0.72
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Ownership Breakdown

Institutions
18.20%
Insiders
29.89%
Retail / Other
51.91%

Top Fund Holders

  • Vanguard International Stock Index-Total Intl Stock Indx
    5.04M1.24%
  • Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund
    2.62M0.64%
  • Vanguard Intl Equity Index Fds-FTSE All World ex U.S.Small Cap Index
    923.36K0.23%
  • Schwab Strategic Tr-Schwab International Small Cap Equity ETF
    504.06K0.12%
  • Allianz Fds Multi Strategy Tr-AllianzGI International Small Cap Fd
    451.75K0.11%
  • Vanguard International Stock Index-Pacific Stock Index
    344.25K0.08%
  • SPDR (R) Idx Shares-SPDR (R) S&P (R) International Small Cap ETF
    209.41K0.05%
  • Allianz Fds-AllianzGI Global Small Cap Fd
    181.78K0.04%
  • Vanguard Intl Equity Index - Total World Stock Index Fd
    117.46K0.03%